TransMedics (TMDX) Net Margin Growth (3y) (2021 - 2026)
TransMedics (TMDX) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | TransMedics | 2.72 Bn | 2.26 Bn | 101.16 Mn | 1,055.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,055.00 |
| Dec 31, 2025 | 3,298.00 |
| Sep 30, 2025 | 4,583.00 |
| Jun 30, 2025 | 7,832.00 |
| Mar 31, 2025 | 8,604.00 |
| Dec 31, 2024 | -32,158.00 |
| Sep 30, 2024 | 24,334.00 |
| Jun 30, 2024 | 13,376.00 |
| Mar 31, 2024 | 12,484.00 |
| Dec 31, 2023 | -25,868.00 |
| Sep 30, 2023 | 2,555.00 |
| Jun 30, 2023 | 24,867.00 |
| Mar 31, 2023 | 10,104.00 |
| Dec 31, 2022 | -42,642.00 |
| Sep 30, 2022 | 8,601.00 |
| Jun 30, 2022 | 10,613.00 |
| Mar 31, 2022 | 8,094.00 |
| Dec 31, 2021 | 54,283.00 |
| Sep 30, 2021 | -11,307.00 |
| Jun 30, 2021 | 8,669.00 |